- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01115205
Supervised Walking Groups as a Model to Increase Physical Activity in Type 2 Diabetes
Assessment of Feasibility and Efficacy of a Project Aimed to Improve Metabolic Control in Type 2 Diabetes Through Lifestyle Changes and Self-monitoring of Blood Glucose
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Regular, moderate-intensity physical activity can attenuate hyperglycemia in subjects with type 2 diabetes. In addition, these programmes may favourably affect several other cardiovascular risk factors in these subjects. However, it still remains unclear how this evidence can be transferred into clinical practice, considering the very large number of diabetic patients and the characteristics of this population, made up predominantly of elderly, sedentary and overweight patients. In this regard, a realistic approach to this issue requires simple and easily available intervention models.
Walking is a typical mild-moderate aerobic physical activity which is easy to organize and does not require specific skills or preliminary sophisticated medical evaluations. This activity could therefore fit well with the need of involvement of large numbers of patients in different logistic situations. However, it has been reported that, due to the low walking speed typical of type 2 diabetic subjects, self-paced walking is inadequate to obtain a significant metabolic improvement in these subjects.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diabetes known for at least 2 yr
- physical inactivity
- haemoglobin (Hb)A1c between 6.5-9.9%
- treatment with oral hypoglycaemic agents alone or associated with a bed-time insulin injection
- willingness to participate in a programme of regular physical activity
Exclusion Criteria:
- moderate-severe autonomic or somatic neuropathy
- severe lower limb vasculopathy
- pre-proliferative or proliferative active retinopathy
- moderate to severe chronic renal failure
- unstable angina or recent (in the previous 3 months) myocardial infarction
- acute intercurrent diseases
- acute metabolic decompensation (blood glucose >300 mg/dl or ketonuria in two consecutive checks)
- use of beta-blocker drugs
- subjects unable to complete a 6-min walk test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Supervised walking groups
Patients included in walking groups, under the supervision of a qualified personal trainer.
|
Walk training, 3 sessions per week for 4 months, under the supervision of a qualified personal trainer.
|
Active Comparator: Controls
Patients receiving the standard counselling procedures of the Verona Diabetic Clinic.
|
Verbal and written information about the benefits of exercise and instructions aimed to encourage physical activity.
In addition, one group session of counselling on these issues.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in haemoglobin A1c (HbA1c) levels
Time Frame: 4 months
|
The measurement of HbA1c is carried out with a DCCT-aligned method.
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Body weight
Time Frame: 4 months
|
4 months
|
|
Change in Fasting plasma glucose levels
Time Frame: 4 months
|
4 months
|
|
Change in Total Cholesterol levels
Time Frame: 4 months
|
4 months
|
|
Change in HDL Cholesterol levels
Time Frame: 4 months
|
4 months
|
|
Change in LDL Cholesterol levels
Time Frame: 4 months
|
4 months
|
|
Change in Triglycerides levels
Time Frame: 4 months
|
4 months
|
|
Change in Blood Pressure
Time Frame: 4 months
|
4 months
|
|
Change in 6 minutes walk distance
Time Frame: 4 months
|
This test measures the number of meters that can be walked in 6 minutes over a 30 m course.
It is a simple field test to assess aerobic functional capacity.
|
4 months
|
Change in C-reactive protein levels
Time Frame: 4 months
|
4 months
|
|
Change in Energy expenditure through voluntary physical activity
Time Frame: 4 months
|
Energy expenditure is estimated through 7-day activity diaries.
The intensity of each activity (defined in metabolic equivalents, MET) is multiplied by duration and the product for each activity is summed to give a total activity score in MET hours/week.
|
4 months
|
Change in Antidiabetic medications
Time Frame: 4 months
|
Class and dosage of blood-glucose lowering drugs are recorded before and at the end of the protocol, to assess changes in hypoglycemic medication during the trial.
|
4 months
|
Compliance with walking sessions
Time Frame: 4 months
|
Attendance at the scheduled walking sessions is recorded for each patient.
|
4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Paolo Moghetti, M.D., Ph.D., Universita di Verona
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CE 1264
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
University of Campania "Luigi Vanvitelli"CompletedType 2 Diabetes MellitusItaly
-
Population Health Research InstituteNovo Nordisk A/SCompletedType 2 Diabetes MellitusCanada
-
Northwell HealthPatient-Centered Outcomes Research InstituteCompletedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina
-
University of MinnesotaUniversity of Southern California; Wake Forest UniversityCompleted
-
Joslin Diabetes CenterDHR Health Institute for Research and Development; Verizon FoundationCompletedType 2 Diabetes MellitusUnited States
Clinical Trials on Supervised walking
-
Texas Tech UniversityRGK FoundationCompletedObesity | Diabetes MellitusUnited States
-
Hong Kong Baptist UniversityNot yet recruiting
-
University of Arkansas, FayettevilleRecruitingDiabetes Mellitus, Type 2United States
-
European University Miguel de CervantesHospital Clínico Universitario de ValladolidCompletedPeripheral Arterial Disease | Intermittent ClaudicationSpain
-
Human Locomotion ScienceUniversity of Southern Denmark; National Board of Health, Denmark; Nordic Institute... and other collaboratorsUnknown
-
University of Illinois at ChicagoNational Institute on Aging (NIA); Midwest Roybal Center for Health Promotion...CompletedChronic Kidney Diseases | Older Adults | Cognitive Function, PreclinicalUnited States
-
Heinrich-Heine University, DuesseldorfUnknownPeripheral Arterial Disease | Intermittent ClaudicationGermany
-
VA Office of Research and DevelopmentRecruitingDiabetes Mellitus | Peripheral Artery Disease | Transtibial AmputationUnited States
-
University of Sao PauloCompletedChronic Low Back PainBrazil
-
University of ManchesterUnknownCardiovascular Diseases | Peripheral Arterial Disease